Plasma factors during chronic HIV-1 infection impair IL-12 secretion by myeloid dendritic cells via a virus-independent pathway.
about
Residual immune dysregulation syndrome in treated HIV infection.Aging of the human innate immune system in HIV infection.Immune activation and HIV persistence: implications for curative approaches to HIV infection.Dendritic cells in progression and pathology of HIV infection.Autologous aldrithiol-2-inactivated HIV-1 combined with polyinosinic-polycytidylic acid-poly-L-lysine carboxymethylcellulose as a vaccine platform for therapeutic dendritic cell immunotherapyAttenuated Listeria monocytogenes vectors overcome suppressive plasma factors during HIV infection to stimulate myeloid dendritic cells to promote adaptive immunity and reactivation of latent virus.Soluble CD40 ligand contributes to dendritic cell-mediated T-cell dysfunction in HIV-1 infection.Functional Impairment of Myeloid Dendritic Cells during Advanced Stage of HIV-1 Infection: Role of Factors Regulating Cytokine SignalingImmunization of HIV-1-Infected Persons With Autologous Dendritic Cells Transfected With mRNA Encoding HIV-1 Gag and Nef: Results of a Randomized, Placebo-Controlled Clinical Trial.Dendritic cell dysregulation during HIV-1 infection.Future considerations for dendritic cell immunotherapy against chronic viral infections.HIV infection: focus on the innate immune cells.Macrophages and Myeloid Dendritic Cells Lose T Cell-Stimulating Function in Simian Immunodeficiency Virus Infection Associated with Diminished IL-12 and IFN-α Production.Vpx-containing dendritic cell vaccine induces CTLs and reactivates latent HIV-1 in vitro.Differential partial activation phenotype and production of tumour necrosis factor-α by conventional dendritic cells in response to lipopolysaccharide in HIV+ viraemic subjects and HIV+ controllers.The Biology of Monocytes and Dendritic Cells: Contribution to HIV Pathogenesis.Advances in dendritic cell immunotherapies for HIV-1 infection.
P2860
Q34020121-A2EED147-245C-40B4-B1EF-486D71727975Q34094201-0536B183-F9E9-4924-B608-6056207A6E7EQ34351320-DB7842D1-B74B-44B3-A281-E92A9C9880DCQ34657557-769EDAC4-4C4D-4F11-9A5B-C027B7DA8300Q34749218-B3CF1DB6-6615-4D75-B474-A36F9EC5367CQ34871958-3F533B02-7B32-441C-A124-26D3F3340E44Q35772650-A1423822-5929-4645-AC54-65B5AE8AB009Q35817342-BF8E9C22-E140-434B-9B6F-64FFA2E7EE58Q36576603-56571BD6-9CB5-4971-8B96-B306CEBBAC9CQ38114911-DD78898E-4EB4-4F14-85D1-BA6D2888FE97Q38204769-98EBC60A-478C-4851-B45C-F3C98B9B00D0Q38945041-245C160B-B48A-48A3-9384-EEC16AB4F01FQ41038551-445BFE9D-E5F5-4C0A-81AB-6AB9DD3F9A83Q41347747-57BB0C56-8A65-46E0-A7D1-73F7431A6507Q42199563-DA2529B2-7D66-446B-8507-5AF454600BB8Q50131761-9BF72F7F-B7E6-4AEB-83C6-1D7D76BF89C7Q51217825-CC5AE746-5730-4D8F-A43F-2D3163228B96
P2860
Plasma factors during chronic HIV-1 infection impair IL-12 secretion by myeloid dendritic cells via a virus-independent pathway.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Plasma factors during chronic ...... a a virus-independent pathway.
@ast
Plasma factors during chronic ...... a a virus-independent pathway.
@en
type
label
Plasma factors during chronic ...... a a virus-independent pathway.
@ast
Plasma factors during chronic ...... a a virus-independent pathway.
@en
prefLabel
Plasma factors during chronic ...... a a virus-independent pathway.
@ast
Plasma factors during chronic ...... a a virus-independent pathway.
@en
P2093
P2860
P1476
Plasma factors during chronic ...... ia a virus-independent pathway
@en
P2093
Davor Frleta
Elizabeth A Miller
Linda Rolnitzky
Meagan P OʼBrien
Meredith R Spadaccia
Nina Bhardwaj
Rachel Sabado
P2860
P304
P356
10.1097/QAI.0B013E31826AFBCE
P407
P577
2012-12-01T00:00:00Z